RB loss promotes aberrant ploidy by deregulating levels and activity of DNA replication factors

Area of Science:

• Cell Biology
• Cancer Biology
• Genomics

Background:

• The retinoblastoma tumor suppressor (RB) is crucial for cell cycle control and genomic stability.
• RB inactivation is common in human cancers, leading to uncontrolled cell proliferation.
• Emerging research suggests RB plays a role in maintaining DNA integrity.

Purpose of the Study:

• To investigate the role of RB in maintaining genomic stability.
• To elucidate the mechanisms by which RB deficiency leads to aberrant DNA content.
• To understand the relationship between RB, DNA replication, and cell cycle control.

Main Methods:

• Utilized mouse adult fibroblasts to study RB-proficient and RB-deficient cells.
• Exposed cells to nocodazole to induce mitotic block and assess cell cycle progression.
• Analyzed DNA content, replication factor levels (MCM7, PCNA), and ploidy.
• Investigated the effects of exogenous expression of replication factors (Cdc6, Cdt1) and E2F.

Main Results:

• RB-deficient cells exhibit aberrant DNA content and increased DNA replication factors.
• RB-deficient cells bypass nocodazole-induced mitotic arrest, continuing DNA synthesis and accumulating higher ploidy and micronuclei.
• DNA replication persists in RB-deficient cells under non-permissive conditions.
• Ectopic E2F expression in RB-proficient cells mimicked RB loss by increasing ploidy and bypassing cell cycle arrest.

Conclusions:

• Deregulated S phase control is a primary mechanism driving elevated ploidy in RB-deficient cells.
• RB loss contributes to genomic instability through aberrant DNA replication and cell cycle bypass.
• Understanding RB's role in DNA replication and cell cycle control is critical for cancer therapy.